BackgroundInvasive fungal infections (IFIs) constitute a significant health challenge. particularly among immunocompromised individuals. characterized by a high prevalence and associated mortality rates. The synergistic administration of Baicalein (BE) with azole antifungal agents could potentially herald a novel therapeutic paradigm. https://lowsbrowcustomers.shop/product-category/riding-gear/